CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Anti-GPRC5D CAR-T Cell Product (OriCAR-017) in Subjects With Relapsed/Refractory Multiple Myeloma.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06271252
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:20.171980+00:00
Published At: 2024-08-02T00:00:00+00:00
Record Updated At: 2024-08-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neoplasms, Plasma Cell", "Neoplasms by Histologic Type", "Neoplasms", "Hemostatic Disorders", "Vascular Diseases", "Cardiovascular Diseases", "Paraproteinemias", "Blood Protein Disorders", "Hematologic Diseases", "Hemorrhagic Disorders", "Lymphoproliferative Disorders", "Immunoproliferative Disorders", "Immune System Diseases", "Multiple Myeloma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-08-02"
protocolSection.identificationModule.nctId: "NCT06271252"
protocolSection.identificationModule.officialTitle: "A Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Anti-GPRC5D CAR-T Cell Product (OriCAR-017) in Subjects With Relapsed/Refractory Multiple Myeloma."
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.